{
    "clinical_study": {
        "@rank": "131097", 
        "arm_group": [
            {
                "arm_group_label": "Erythropoietin alpha", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Deferasirox + Erythropoietin alpha", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this trial is to assess the effect of treatment with deferasirox\n      combined with erythropoietin vs. erythropoietin alone on erythropoiesis in patients with\n      low- and int-1-risk myelodysplastic syndrome.\n\n      The addition of deferasirox to erythropoietin could lead to a potential synergism with the\n      reduction of reactive oxygen species, through both the NF-kB pathway and the control of free\n      toxic iron. This may create a better environment in the bone marrow for a better response\n      with erythropoietin.\n\n      This study is designed to test in a prospective way the combination of deferasirox with\n      erythropoietin in term of their effect on hematopoiesis."
        }, 
        "brief_title": "Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Adult Patients With Low- and Int-1-risk Myelodysplastic Syndrome.", 
        "condition_browse": {
            "mesh_term": [
                "Myelodysplastic Syndromes", 
                "Preleukemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with low- and Int-1-risk myelodysplastic syndrome\n\n          -  Documented diagnosis of the following:\n\n        Myelodysplastic syndrome lasting \u2265 3 months and < 2 years Disease must not be secondary to\n        treatment with radiotherapy, chemotherapy, and/or immunotherapy for malignant or\n        autoimmune diseases\n\n          -  A hemoglobin < 10 g/dL and > 6 g/dL (no RBC transfusions are allowed during study)\n\n          -  History of transfusions < 10 RBC units\n\n          -  300 ng/mL < serum ferritin < 1,000 ng/mL\n\n          -  Endogenous erythropoietin levels < 500 units/L\n\n        Exclusion Criteria:\n\n          -  Patients with MDS with isolated del(5q)\n\n          -  Patients who had received prior EPO treatment or other recombinant growth factors\n             regardless of the outcome (Patient who had received prior EPO treatment or other\n             recombinant growth factors for less than 4 weeks and not within 3 months before\n             screening without a documented response are allowed)\n\n          -  Patients receiving steroids or immunosuppressive therapy for the improvement of\n             hematological parameters (prophylactic hydrocortisone to prevent transfusion\n             reaction, steroid for adrenal failure, and intermittent dexamethasone as antiemetic\n             are allowed).\n\n          -  B12 and folate deficient patients (patients could be rescreened after successful\n             therapy of B12 and folate deficiency)\n\n          -  Uncontrolled seizures or uncontrolled hypertension\n\n        Other protocol-defined inclusion/exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01868477", 
            "org_study_id": "CICL670A2421"
        }, 
        "intervention": [
            {
                "arm_group_label": "Erythropoietin alpha", 
                "intervention_name": "Erythropoietin alpha", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Deferasirox + Erythropoietin alpha", 
                "intervention_name": "Erythropoietin alpha", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Deferasirox + Erythropoietin alpha", 
                "intervention_name": "Deferasirox", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epoetin Alfa", 
                "Deferasirox"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 10, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Fayetteville", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72703"
                    }, 
                    "name": "Highlands Oncology Group Dept of Highlands Oncology Grp"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "crandall@carti.com", 
                    "last_name": "Carla Randall", 
                    "phone": "501-320-3217"
                }, 
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }, 
                    "name": "Hematology Oncology Services of Arkansas SC"
                }, 
                "investigator": {
                    "last_name": "Brad Baltz", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "javierz@pacificcancer.com", 
                    "last_name": "Javier Zuniga", 
                    "phone": "714-999-1465"
                }, 
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Pacific Cancer Medical Center, Inc."
                }, 
                "investigator": {
                    "last_name": "Ajit S Maniam", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Honolulu", 
                        "country": "United States", 
                        "state": "Hawaii", 
                        "zip": "96813"
                    }, 
                    "name": "University of Hawaii Cancer Center SC ICL670A2421"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush University Medical Center Rush University"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "raabdelh@montefiore.org", 
                    "last_name": "Rana Abdelhamid", 
                    "phone": "718-920-6642"
                }, 
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10467-2490"
                    }, 
                    "name": "Montefiore Medical Center SC ICL670A2421"
                }, 
                "investigator": {
                    "last_name": "Olga Derman", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29601"
                    }, 
                    "name": "Bon Secours St. Francis Hospital"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oran", 
                        "country": "Algeria", 
                        "zip": "31000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sidi Bel abbes", 
                        "country": "Algeria", 
                        "zip": "22000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caba", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "C1221ADC"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Plata", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "B1900AWT"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria", 
                        "zip": "1756"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varna", 
                        "country": "Bulgaria", 
                        "zip": "9000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V6Z1Y6"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8V 5C2"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M4N 3M5"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "12200"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duesseldorf", 
                        "country": "Germany", 
                        "zip": "40225"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rostock", 
                        "country": "Germany", 
                        "zip": "18107"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cagliari", 
                        "country": "Italy", 
                        "state": "CA", 
                        "zip": "09100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "state": "FI", 
                        "zip": "50134"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reggio Calabria", 
                        "country": "Italy", 
                        "state": "RC", 
                        "zip": "89124"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "RM", 
                        "zip": "00161"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "state": "Korea", 
                        "zip": "135-710"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "738-736"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hospitalet de LLobregat", 
                        "country": "Spain", 
                        "state": "Catalunya", 
                        "zip": "08907"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Girona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "17007"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baracaldo", 
                        "country": "Spain", 
                        "state": "Pais Vasco", 
                        "zip": "48903"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28006"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28033"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gothenburg", 
                        "country": "Sweden", 
                        "zip": "413 45"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "SE-581 85"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lule\u00e5", 
                        "country": "Sweden", 
                        "zip": "SE-971 80"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "SE-118 83"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "SE-141 86"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sundsvall", 
                        "country": "Sweden", 
                        "zip": "851 86"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cambridge", 
                        "country": "United Kingdom", 
                        "state": "Cambrigdeshire", 
                        "zip": "CB2 0QQ"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oldham", 
                        "country": "United Kingdom", 
                        "state": "Lancashire", 
                        "zip": "OL1 2JH"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "NW1 2PJ"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Algeria", 
                "Argentina", 
                "Bulgaria", 
                "Canada", 
                "Germany", 
                "Italy", 
                "Korea, Republic of", 
                "Spain", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "An Open-label, Phase II, Randomized, Pilot Study to Assess the Effect in Term of Erythroid Improvement of Deferasirox Combined With Erythropoietin Compared to Erythropoietin Alone in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Sweden: Medical Products Agency", 
                "Korea: Food and Drug Administration", 
                "Canada: Health Canada", 
                "Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica", 
                "Colombia: INVIMA Instituto Nacional de Vigilancia de Medicamentos y Alimentos", 
                "Hungary: National Institute of Pharmacy", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Bulgaria: Bulgarian Drug Agency", 
                "Italy: The Italian Medicines Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Difference in proportion of patients achieving an erythroid response within 12 weeks of treatment between the two arms according to modified IWG 2006 criteria (increase in Hb \u2265 1.5 g/dL)", 
            "measure": "Change in hemoglobin levels", 
            "safety_issue": "No", 
            "time_frame": "Within 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01868477"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Proportion of patients achieving a hematological response within 24 weeks of treatment with deferasirox combined with Erythropoietin alpha (increase in hemoglobin, improvement of neutropenia and thrombocytopenia) according to modified IWG 2006 criteria", 
                "measure": "Change in hemoglobin, platelets and neutrophil levels", 
                "safety_issue": "No", 
                "time_frame": "Within 24 weeks"
            }, 
            {
                "description": "Proportion of patients achieving an erythroid response according to modified IWG 2006 criteria (increase in Hb \u2265 1.5 g/dL) within 24 weeks", 
                "measure": "Change in hemoglobin levels", 
                "safety_issue": "No", 
                "time_frame": "Within 24 weeks"
            }, 
            {
                "description": "Time to response is defined as the time from date of start of treatment to the date of event defined as  the first documented response according to modified IWG 2006 criteria (increase in Hb \u2265 1.5 g/dL)", 
                "measure": "Time to erythroid response", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "description": "Time to response is defined as the time from date of start of treatment to the date of event defined as the first documented response (increase in hemoglobin, improvement of neutropenia and thrombocytopenia) according to modified IWG 2006 criteria", 
                "measure": "Time to hematologic improvement", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "description": "Duration of response is defined as the time from onset of the first response to progression/relapse (decrease in Hb \u2265 1.5 g/dL from Hb value at response)", 
                "measure": "Duration of erythroid response", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "description": "Incidence of adverse events (AEs) overall and by severity, and serious adverse events (SAEs)", 
                "measure": "Number of adverse events (AEs) and serious adverse events (SAEs)", 
                "safety_issue": "Yes", 
                "time_frame": "up to 6 months"
            }, 
            {
                "description": "Change in serum ferritin from baseline to every month throughout the study in the combination arm", 
                "measure": "Iron parameters by change in serum ferritin", 
                "safety_issue": "No", 
                "time_frame": "Baseline, followed by evaluation after 1, 2, 3, 4, 5 and 6 months"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}